Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7403 p653
3 June 2006

This article
Reprint   Photocopy

PDF 40K, Acrobat Reader

Letters

· DTB
· Education
· Independent prescribing (2)
· Medicines use reviews (2)
· Section 60 Order
· Council election
· The Council


Letters to the Editor

Drug & Therapeutics Bulletin

Disappointed with Department of Health decision

From Miss M. V. Mott, MRPharmS

I would like to express my concern and disappointment that the contract for the Drug & Therapeutics Bulletin, provided centrally to the NHS, is to be stopped. I am at a loss to understand the rationale for this decision and have written to Patricia Hewitt urging her to reconsider.

I have just attended a staff briefing at which our chief executive outlined plans to save money within the trust, including a significant number of redundancies. This is to occur in an environment where staff are already routinely working over their core hours, without remuneration, just to provide basic patient care.

I am one of the lucky ones and get to keep my job. However, I have to make vast reductions (up to 80 per cent) to the amount I spend on the resources I need to do my job. The DTB is one of these key resources. The UK Medicines Information network considers the DTB to be an essential reference source for all medicines information centres. My colleagues and I rely on the unbiased, high-quality information in such bulletins to provide clinically effective and cost-efficient medicines information to clinical colleagues and to underpin formulary development.

By decentralising the funding for this essential resource it will end up costing the NHS more in the long run. Alternatively, patient care will be compromised by trusts that decide they cannot afford to subscribe or which sacrifice other essential resources in order to fund this one. I find it difficult to comprehend why the decision to end the contract has been taken when it is resources like this that enable NHS procurement budgets to be made as cost-efficient as possible.

In summary, I strongly suggest the Department of Health reconsiders its position. The DTB is a nationally recognised, gold-standard resource that is essential for provision of cost-effective health care in the NHS.

Victoria Mott
Lead Medicines Information Pharmacist
The John Radcliffe Hospital, Oxford

Send your letter to The Editor

Next Topic (Education)

Back to Top


©The Pharmaceutical Journal